PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $208,716 | -95.8% | 6,803 | -94.5% | 0.00% | -95.8% |
| Q2 2023 | $4,983,987 | -38.2% | 124,382 | +8.0% | 0.05% | -11.1% |
| Q1 2021 | $8,071,000 | -14.1% | 115,157 | -26.7% | 0.05% | -30.8% |
| Q4 2020 | $9,400,000 | +1.9% | 157,090 | +2.4% | 0.08% | -22.0% |
| Q3 2020 | $9,225,000 | +6.4% | 153,443 | -7.2% | 0.10% | +4.2% |
| Q2 2020 | $8,673,000 | +29806.9% | 165,300 | +18813.0% | 0.10% | – |
| Q1 2020 | $29,000 | -21.6% | 874 | +7.1% | 0.00% | – |
| Q4 2019 | $37,000 | -7.5% | 816 | -23.0% | 0.00% | – |
| Q3 2019 | $40,000 | – | 1,060 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |